Search

everythinglearnresearchcommunity

for

Search:↓

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

Scalp cooling can prevent hair loss in 65% of chemotherapy patients, especially effective in breast cancer patients and certain chemotherapy types.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Hirsutism in women often indicates a hormonal imbalance and can be managed with a combination of hormonal treatments and hair removal methods.

5α-reductase inhibitors like finasteride may not be effective or safe for transgender individuals, and more research is needed.

A new anti-baldness patch effectively treats hair loss by blocking enzymes linked to the condition.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Hormone therapy increases facial and body hair in transgender men, while hair removal improves well-being in transgender women, but cost is a barrier as insurance often doesn't cover it. Dermatologists can use various treatments for these hair issues.

Finger length ratio may indicate male hair loss.

Most transgender patients getting laser hair removal before gender-affirming surgery are already on hormone therapy, which might affect the hair removal process.

Hormones and signaling pathways control sebaceous gland function and could help treat acne.

Hormone treatment for transsexual individuals is effective but carries risks like thromboembolic events and mood changes, with most side effects being minor and reversible.

Finasteride and dutasteride do not significantly change beard thickness in men.

Topical minoxidil helps transgender individuals assigned female at birth grow more facial hair.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

Women with excessive hair growth tend to have shorter index and ring fingers compared to others.

Sebum production varies by individual and is influenced by age, gender, and hormones, affecting skin and hair health.

Pfizer found that pantolactam-based compounds can reduce sebum (skin oil) production when applied topically.

The document recommends using both clinical evaluation and various measurement methods to assess skin greasiness, considering factors like temperature and hormones.

Sebaceous glands in our skin, developing during pregnancy and active in puberty, produce sebum for skin lubrication, temperature control, and fighting germs, also help in hormone regulation, and their dysfunction can cause conditions like acne and hair loss.

Lower melatonin levels are linked to more skin aging.

The oral contraceptive improved hair and skin quality in women.

Cidea is essential for proper lipid storage and secretion in sebaceous glands, affecting skin and hair health.

Most white Spanish women have a widow's peak, and their hairline measurements could help in hair restoration surgery.

Most Spanish Caucasian women have a widow's peak, and their hormone levels suggest they process certain hormones faster.

Menopause reduces skin collagen and elasticity, and while estrogen therapy can help, its risks require careful consideration.

The congress showed advancements in skin hydration, barrier function, and safe, effective new cosmetic formulations.

Hibiscus rosa-sinensis is effective and safe for use in herbal soaps and hair oils, promoting skin and hair health.